Order Article Reprints

Schettini F, Giuliano M, Giudici F, Conte B, De Placido P, Venturini S, Rognoni C, Di Leo A, Locci M, Jerusalem G, et al. Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis. Cancers. 2021; 13(6):1458. https://doi.org/10.3390/cancers13061458

Schettini, Francesco, Mario Giuliano, Fabiola Giudici, Benedetta Conte, Pietro De Placido, Sergio Venturini, Carla Rognoni, Angelo Di Leo, Mariavittoria Locci, Guy Jerusalem, and et al. 2021. "Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis" Cancers 13, no. 6: 1458. https://doi.org/10.3390/cancers13061458

Schettini, F., Giuliano, M., Giudici, F., Conte, B., De Placido, P., Venturini, S., Rognoni, C., Di Leo, A., Locci, M., Jerusalem, G., Del Mastro, L., Puglisi, F., Conte, P., De Laurentiis, M., Pusztai, L., Rimawi, M. F., Schiff, R., Arpino, G., De Placido, S., ... Generali, D. (2021). Endocrine-Based Treatments in Clinically-Relevant Subgroups of Hormone Receptor-Positive/HER2-Negative Metastatic Breast Cancer: Systematic Review and Meta-Analysis. Cancers, 13(6), 1458. https://doi.org/10.3390/cancers13061458